Margaret Olinger

Margaret Olinger

Former Chief Commercial OfficeratAmylyx Pharmaceuticals· In proxies 2021–2023

Pay in FY2023+15% from the year before · Amylyx Pharmaceuticals stock -60.2% the same year

Margaret Olinger was paid $3.4M in FY2023 (Dec), up 15%. Amylyx Pharmaceuticals stock fell 60.2% that year.

Pay$100 in the stock at the end of FY22 → $40
Pay is from the Summary Compensation Table of each Amylyx Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Amylyx PharmaceuticalsPublic company · 5 yr
    • Former Chief Commercial Officer2021 – Present · 5 yrStock in role +55%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?